Log In
Print
BCIQ
Print
Print this Print this
 

MCNA (EN3348) (formerly Urocidin)

  Manage Alerts
Collapse Summary General Information
Company Telesta Therapeutics Inc.
DescriptionMycobacterial cell wall-DNA complex (MCC)
Molecular Target Not applicable
Mechanism of ActionImmune modulation; Apoptosis stimulator
Therapeutic Modality 
Latest Stage of DevelopmentRegistration
Standard IndicationBladder cancer
Indication DetailsTreat bladder cancer; Treat non-muscle invasive bladder cancer; Treat superficial bladder cancer (SBC)
Regulatory Designation
Partner BL&H Co. Ltd.; Endo International plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$147.6M

$20.0M

$125.4M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today